Clinical Trial Update: Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study [Phase 3]

View source ↗

Summary

A Phase 3 prospective study assessing safety and efficacy of tissue plasminogen activator (tPA) for intra-abdominal collections in children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Abscess

Drugs mentioned

• tPA (tissue plasminogen activator) (tissue plasminogen activator)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Intra-abdominal Abscess | Phase 3 | Status: TERMINATED